Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Zaprinast potentiates beneficial effects of inhaled NO in hypoxic pulmonary hypertension

Nov. 5, 1997

Novel antihypertensive agent developed in Taiwan

Nov. 4, 1997

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

Nov. 3, 1997

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Nov. 3, 1997

Clevidipine lowers MAC of anesthetic in animal study

Nov. 3, 1997

Phase II results promising for E-047/1 following CABG

Nov. 3, 1997

Merck KGaA reports two new series of ET antagonists

Nov. 3, 1997

Recordati's lercanidipine launched in The Netherlands

Oct. 31, 1997

Mibefradil and amlodipine compared in patients with exercise-induced and silent ischemia

Oct. 30, 1997

Effects of NO donor ITF-1129 on blood flow/hemodynamics during myocardial ischemia

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...